--- title: "EssilorLuxottica (ENXTPA:EL) Valuation In Focus As Smart Glasses And Supreme Acquisition Shape Investor Sentiment" type: "News" locale: "en" url: "https://longbridge.com/en/news/286516251.md" description: "EssilorLuxottica (ENXTPA:EL) faces investor skepticism due to execution risks in smart glasses and apparel, with a current share price of €173.2, down 15.39% in a month and 34.76% year-to-date. Despite a 5-year total shareholder return of 35.84%, the market questions the company's growth potential. Analysts suggest a fair value of €400.08, indicating the stock may be undervalued. However, concerns about smart glasses adoption and brand integration persist, alongside a high P/E ratio of 34.5x, suggesting valuation risks if expectations falter." datetime: "2026-05-15T06:10:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286516251.md) - [en](https://longbridge.com/en/news/286516251.md) - [zh-HK](https://longbridge.com/zh-HK/news/286516251.md) --- # EssilorLuxottica (ENXTPA:EL) Valuation In Focus As Smart Glasses And Supreme Acquisition Shape Investor Sentiment Recent commentary around EssilorLuxottica Société anonyme (ENXTPA:EL) has focused on how the market is reacting to perceived execution risks in smart glasses and branded apparel, even as the company continues acquiring brands like Supreme. See our latest analysis for EssilorLuxottica Société anonyme. At a share price of €173.2, EssilorLuxottica’s 1 month share price return is down 15.39% and the year to date share price return is down 34.76%. However, the 5 year total shareholder return of 35.84% points to a much more resilient long term picture. This suggests recent momentum has faded as investors reassess growth execution risks around smart glasses and new apparel brands. If you want to see how other companies exposed to advanced optics and automation are trading, it could be worth scanning opportunities in 32 robotics and automation stocks With EssilorLuxottica trading well below some analyst estimates and recent returns under pressure, the key question for you is simple: is this a reset that opens up value, or is the market fairly pricing future growth? ## Most Popular Narrative: 56.7% Undervalued According to the most followed narrative on EssilorLuxottica, a fair value of €400.08 sits well above the last close at €173.2, which raises clear questions about how much of its smart eyewear and apparel ambitions the market is currently willing to price in. > _EssilorLuxottica, a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, continues to redefine the eyewear industry through technological innovation and strategic acquisitions. With a diverse portfolio that includes iconic brands like Oakley and the recent addition of Supreme, the company is poised to enhance its market presence and consumer engagement._ Read the complete narrative. This narrative emphasizes compound revenue growth, expanding margins and a premium profit multiple that assumes smartwear, Supreme and the wider brand portfolio work together at scale. Want to see how those moving parts combine to reach more than double the current share price in the model? **Result: Fair Value of €400.08 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, this story can unravel if smart glasses adoption slows or if Supreme and other apparel brands struggle to connect with consumers and dilute focus on core eyewear. Find out about the key risks to this EssilorLuxottica Société anonyme narrative. ## Another View: What The P/E Ratio Is Saying While the popular narrative leans on future cash flows and a €400.08 fair value, the current P/E of 34.5x paints a stricter picture. It sits above the European Medical Equipment industry at 25.3x, peers at 32.5x, and even a fair ratio of 27.6x, which points to valuation risk if expectations slip. So which signal do you trust more: the optimism in the growth story or the premium already baked into the price? To see how these comparisons stack up in numbers you can work with, take a closer look at the detailed valuation breakdown in See what the numbers say about this price — find out in our valuation breakdown. ENXTPA:EL P/E Ratio as at May 2026 ## Next Steps Given the mix of optimism and concern running through this story, it makes sense to move quickly, review the full data set yourself, and decide whether the balance of risks and rewards fits your own approach, starting with the 2 key rewards and 1 important warning sign ## Looking for more investment ideas? If EssilorLuxottica has sharpened your focus on valuation and risk, do not stop here. Widen the lens and compare it with other opportunities that match your style. - Target potential mispricings by scanning 233 high quality undervalued stocks that combine quality fundamentals with room for market sentiment to catch up. - Prioritise resilience by checking solid balance sheet and fundamentals stocks screener (392 results) where companies show stronger financial foundations and lower balance sheet pressure. - Get in early on future stories by reviewing the screener containing 547 high quality undiscovered gems that the wider market may not be focused on yet. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Valuation is complex, but we're here to simplify it. Discover if EssilorLuxottica Société anonyme might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [ESLOY.US](https://longbridge.com/en/quote/ESLOY.US.md) ## Related News & Research - [EssilorLuxottica SA (0OMK) was upgraded to a Hold Rating at Deutsche Bank](https://longbridge.com/en/news/286064286.md) - [EssilorLuxottica Shares Fall as Investors Weigh Impact of Smartglasses](https://longbridge.com/en/news/283793167.md) - [Barclays Keeps Their Buy Rating on EssilorLuxottica SA (0OMK)](https://longbridge.com/en/news/285933914.md) - [Assessing BioMarin Pharmaceutical (BMRN) Valuation After Prolonged Share Price Weakness](https://longbridge.com/en/news/286895616.md) - [BUZZ-Deutsche Bank starts EssilorLuxottica at 'hold' on demand, tech competition risks](https://longbridge.com/en/news/286065772.md)